Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Sanne Bevers, Sander A.A. Kooijmans, Elien Van de Velde, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 3078-3094
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 87
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Strategies for non-viral vectors targeting organs beyond the liver
Jeonghwan Kim, Yulia Eygeris, Renee C. Ryals, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 4, pp. 428-447
Closed Access | Times Cited: 42
Towards realizing nano-enabled precision delivery in plants
Gregory V. Lowry, Juan Pablo Giraldo, Nicole F. Steinmetz, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 9, pp. 1255-1269
Open Access | Times Cited: 22
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 20
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 19
Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles
Jacob L. Thelen, Wellington Leite, Volker S. Urban, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1464-1476
Closed Access | Times Cited: 17
mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 37
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 30
mRNA nanodelivery systems: targeting strategies and administration routes
Mujie Yuan, Zeyu Han, Yan Liang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 28
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 26
mRNA: A promising platform for cancer immunotherapy
Byoungjae Kong, Yelee Kim, Eun Hye Kim, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114993-114993
Open Access | Times Cited: 21
mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer
Ke Qiu, Xing Duan, Minzi Mao, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3595-3595
Open Access | Times Cited: 10
Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo
Tian Zhang, Han Yin, Li Yu, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109804-109804
Open Access | Times Cited: 10
Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery
Emily De Lombaerde, Yong Chen, Tingting Ye, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 21
Open Access | Times Cited: 8
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 8
Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 8
Therapeutic Vaccines for HPV-Associated Cervical Malignancies: A Systematic Review
Souhail Alouini, Chantal Pichon
Vaccines (2024) Vol. 12, Iss. 4, pp. 428-428
Open Access | Times Cited: 7
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 20
The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
Аlbert R. Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14820-14820
Open Access | Times Cited: 19
Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies
Ildus Pateev, Kristina Seregina, Roman Ivanov, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 59-59
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top